| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/27/1995 | WO1995020044A1 Natural resistance associated macrophage protein and uses thereof |
| 07/27/1995 | WO1995019993A1 Protein kinases |
| 07/27/1995 | WO1995019992A1 Compositions and methods using unbound mpl receptor for stimulating platelet production |
| 07/27/1995 | WO1995019991A1 New composition of glycoprotein isoforms having follicle stimulating activity |
| 07/27/1995 | WO1995019990A1 A novel protein from aedes albopictus cells and methods for its use |
| 07/27/1995 | WO1995019989A1 PORE FORMING PEPTIDES FROM $i(GEOLYCOSA RIOGRANDE) |
| 07/27/1995 | WO1995019985A1 Haemopoietic maturation factor |
| 07/27/1995 | WO1995019965A1 Synthetic matrix metalloprotease inhibitors and uses thereof |
| 07/27/1995 | WO1995019958A1 Malarial aspartic protease inhibitors |
| 07/27/1995 | WO1995019790A1 Humanized antibodies against leukocyte adhesion molecule vla-4 |
| 07/27/1995 | WO1995019789A1 Motor-function disorder preventive or remedy |
| 07/27/1995 | WO1995019788A1 Inhibitors and target molecule co-localization |
| 07/27/1995 | WO1995019787A1 Aqueous prolonged release formulation |
| 07/27/1995 | WO1995019786A1 Use of interleukin-12 to prevent graft versus host disease |
| 07/27/1995 | WO1995019785A1 Treatment for juvenile diabetes |
| 07/27/1995 | WO1995019784A1 Human therapeutic uses of bpi protein products |
| 07/27/1995 | WO1995019780A1 Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity |
| 07/27/1995 | WO1995019779A1 Deltex proteins, nucleic acids, and antibodies, and related methods and compositions |
| 07/27/1995 | WO1995019777A2 Use of diesters of muramyl peptides in oral form as immunostimulating agents |
| 07/27/1995 | WO1995019769A1 Combinations of a creatine compound with a hyperplastic inhibitory agent for inhibiting undesirable cell growth |
| 07/27/1995 | WO1995014778A3 Dna sequence coding for a bmp receptor |
| 07/27/1995 | WO1995011975A3 Retroviral superantigens, superantigen peptides, and methods of use |
| 07/27/1995 | CA2181899A1 Use of diesters of muramyl peptides in oral form as immunostimulating agents |
| 07/27/1995 | CA2181816A1 Human therapeutic uses of bpi protein products |
| 07/27/1995 | CA2181711A1 New composition of glycoprotein isoforms having follicle stimulating activity |
| 07/27/1995 | CA2181592A1 Pore forming peptides from geolycosa riogrande |
| 07/27/1995 | CA2181551A1 Malarial aspartic protease inhibitors |
| 07/27/1995 | CA2181544A1 Natural resistance associated macrophage protein and uses thereof |
| 07/27/1995 | CA2181431A1 Haemopoietic maturation factor |
| 07/27/1995 | CA2181230A1 Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity |
| 07/27/1995 | CA2180834A1 Antibodies to egf receptor and their antitumour effect |
| 07/27/1995 | CA2178610A1 Aqueous prolonged release formulations of somatotropin |
| 07/27/1995 | CA2158760A1 Synthetic matrix metalloprotease inhibitors and uses thereof |
| 07/27/1995 | CA2157015A1 Inhibitors and target molecule co-localization |
| 07/27/1995 | CA2126361A1 Gene encoding cationic amino acid transporter protein |
| 07/26/1995 | EP0664298A1 Sex-associated membrane proteins and methods for increasing the probability that offspring will be of a desired sex |
| 07/26/1995 | EP0664297A1 Use of cyclic Didepsipeptides having 12 ring atoms to control endoparasites, novel cyclic depsipeptides with 12 ring atoms and process for their synthesis |
| 07/26/1995 | EP0664001A1 Method for screening hiv-1 positive individuals using antibodies against sulfatide |
| 07/26/1995 | EP0663958A1 Inhibition of cyst formation by cytoskeletal specific drugs |
| 07/26/1995 | EP0663954A1 Ptp 1d: a novel protein tyrosine phosphatase |
| 07/26/1995 | EP0663951A1 Chitosan matrices for encapsulated cells |
| 07/26/1995 | EP0663916A1 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
| 07/26/1995 | EP0663837A1 Prevention of suppression of immune defense against cancer caused by the cancer-associated scm-recognition peptide |
| 07/26/1995 | EP0663834A1 Growth hormone releasing peptides |
| 07/26/1995 | EP0663826A1 Amino acids containing parenteral formulations for the treatment of hypotension and related pathologies |
| 07/26/1995 | EP0663823A1 Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors |
| 07/26/1995 | EP0630181A4 Nutritional product for trauma and surgery patients. |
| 07/26/1995 | EP0627911A4 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers. |
| 07/26/1995 | EP0596929B1 Amide derivatives of antibiotic a 40926 |
| 07/26/1995 | EP0416037B1 Superoxide dismutase analogs having novel binding properties |
| 07/26/1995 | CN1105800A Selective crosslinking of hemoglobins by oxidized, ring-opened saccharides |
| 07/26/1995 | CN1105596A Chymotrypsin pessary for curing sperma non-liquefaction |
| 07/25/1995 | US5436355 Parasiticdes, bactericides |
| 07/25/1995 | US5436321 Antibodies to the lipopolysaccharide bonding opsonin septin |
| 07/25/1995 | US5436319 Lymphocytes for immunoassay |
| 07/25/1995 | US5436318 Hepatitis C virus epitopes |
| 07/25/1995 | US5436230 Using growth factor as slimming agent |
| 07/25/1995 | US5436229 Bisulfite adducts of arginine aldehydes |
| 07/25/1995 | US5436228 Chemotactic wound healing peptides |
| 07/25/1995 | US5436222 Use of platelet factor 4 to treat inflammatory diseases |
| 07/25/1995 | US5436221 Oligopeptides as antitumor agents |
| 07/25/1995 | US5436163 Kit for typing platelet alloantigens comprising means for amplifying gene, receptacle containing labeled oligonucleotide probe or restriction endonuclease to distinguish sequences |
| 07/25/1995 | US5436162 Human manganese superoxide dismutase (hMn-SOD) |
| 07/25/1995 | US5436157 Human intra-acrosomal sperm antigen |
| 07/25/1995 | US5436154 Stable hybridoma cells and antigen-antibodies |
| 07/25/1995 | US5436153 Human amyloid protein precursor homolog and Kunitz-type inhibitor |
| 07/25/1995 | US5436140 Process for producing WS-9326A and WS-9326B |
| 07/25/1995 | US5436137 Promoting fertilization |
| 07/25/1995 | US5436004 Capsules with carriers and cholesterol reductase as anticholesterol agents |
| 07/25/1995 | US5436003 Method of alleviating gastrointestinal distress with a composition containing beta-fructofuransidase, cellulase and hemi-cellulase |
| 07/25/1995 | US5436002 Bacillus thuringiensisisolate PS201T6 toxin |
| 07/25/1995 | US5435999 Cytokines for cell proliferation |
| 07/25/1995 | CA2140834A1 Method for removing the prions in collagens and collagens thereby obtained |
| 07/25/1995 | CA1336409C Tumor or cancer cell killing therapy and agents useful therefor |
| 07/25/1995 | CA1336404C General cancer-associated scm-recognition factor, preparation and method of use |
| 07/25/1995 | CA1336403C Human relaxin formulation |
| 07/25/1995 | CA1336401C Intranasal administration of polypeptides in powdered form |
| 07/25/1995 | CA1336400C Method for treating renal diseases |
| 07/25/1995 | CA1336399C Adjuvant for cancer immunotherapy |
| 07/25/1995 | CA1336398C Method for reducing side effects of cancer therapy |
| 07/25/1995 | CA1336397C Methyl cellulose pharmaceutical composition |
| 07/25/1995 | CA1336396C Intraocular anticoagulant including antithrombin iii and method of administration |
| 07/21/1995 | CA2140591A1 Antigen-specific, activated t lymphocytes, detection and use |
| 07/20/1995 | WO1995019568A1 Hydrophilic signal oligopeptides and methods of therapeutic use |
| 07/20/1995 | WO1995019437A1 Cross-reactive allergen |
| 07/20/1995 | WO1995019436A1 Mammalian monocyte chemoattractant protein receptors |
| 07/20/1995 | WO1995019435A2 T cell antigen receptor v region proteins and methods of preparation thereof |
| 07/20/1995 | WO1995019434A1 Tissue-specific enhancer active in prostate |
| 07/20/1995 | WO1995019433A2 Anti-hepatitis b poly- and oligonucleotides |
| 07/20/1995 | WO1995019431A1 Zinc finger protein derivatives and methods therefor |
| 07/20/1995 | WO1995019430A1 Macroencapsulated secretory cells |
| 07/20/1995 | WO1995019429A2 Method and reagent for inhibiting hepatitis c virus replication |
| 07/20/1995 | WO1995019375A1 Peptides and methods against psoriasis |
| 07/20/1995 | WO1995019372A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 07/20/1995 | WO1995019371A2 Expression of surface layer proteins |
| 07/20/1995 | WO1995019370A1 Ion-channel forming amphiphilic peptides having n-terminal modifications |
| 07/20/1995 | WO1995019187A1 Biological targeting agents |
| 07/20/1995 | WO1995019183A1 Cd44 expression in smooth muscle cells |
| 07/20/1995 | WO1995019182A1 Somatic gene therapy to cells associated with fluid spaces |
| 07/20/1995 | WO1995019181A1 A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS |